Physician profile
Michael E Gauthier
NPI 1477518207
$2,146.93
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2021: $289 · 2022: $1,069 · 2023: $502 · 2024: $60.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,573.31 | 2021-2024 | Intellis Adaptivestim, Synchromedii, Osteocool Rf Ablation System |
| Medtronic USA, INC. | $149.30 | 2019 | |
| Nevro Corp. | $138.03 | 2022-2023 | Senza |
| Boston Scientific Corporation | $108.45 | 2022 | |
| Abbott Laboratories | $54.46 | 2023-2024 | Proclaim |
| Pacira Therapeutics, INC. | $27.72 | 2019 | |
| Si-Bone, INC. | $26.39 | 2022 | |
| Merz North America, INC. | $21.24 | 2019 | |
| Fidia Pharma USA INC. | $20.89 | 2022 | |
| Avanos Medical | $16.81 | 2019 | |
| Electronic Waveform Lab, INC. | $10.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gauthier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.